{Reference Type}: Case Reports
{Title}: Malignant phyllodes tumor with EGFR variant III mutation: A rare case report with immunohistochemical and genomic studies.
{Author}: Kitazono I;Akahane T;Sasaki H;Ohi Y;Shinden Y;Takajo T;Tasaki T;Higashi M;Noguchi H;Hisaoka M;Tanimoto A;
{Journal}: Pathol Res Pract
{Volume}: 259
{Issue}: 0
{Year}: 2024 Jul 2
{Factor}: 3.309
{DOI}: 10.1016/j.prp.2024.155389
{Abstract}: A female in her 60's presented with a left-sided breast mass. A core needle biopsy specimen showed diffuse proliferation of a round cell tumor, which was positive for vimentin, NKX2.2, BCOR, and focal CD99 on immunohistochemistry (IHC). No fusion genes of the Ewing family sarcomas were detected. With a tentative diagnosis of primary breast sarcoma (PBS), total mastectomy was performed after chemotherapy. The resected tissues showed proliferation of round or spindle-shaped tumor cells with a high nuclear-to-cytoplasmic ratio, exhibiting solid and fascicular arrangements but no epithelial component or organoid pattern. While IHC indicated no particular histological diagnosis, genomic examination revealed gene alterations in MED12 p.G44D, MLL2 (KMT2D) p.T1496fs*27, and EGFR variant III (vIII). Moreover, a retrospective IHC study showed overexpression of EGFRvIII. A malignant phyllodes tumor (PT) with extensive sarcomatous overgrowth was indicated as an integrative diagnosis. This is a rare case of a malignant PT harboring EGFRvIII. The present case provides an importance of accurate diagnosis and genomic analysis of rare breast tumors, as malignant PT and PBS are different in its treatment strategy and prognosis.